Advertisements

Биодроксил

Quick links to important sections

Биодроксил

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Биодроксил

Quick Facts

Property Description
Active ingredient Cefadroxil
Form Capsule, Tablet, Oral Suspension (powder)
Pharmacological class First-Generation Cephalosporin Antibiotic
General purpose Elimination of susceptible bacterial pathogens
Origin Semisynthetic

What is Биодроксил and What Type of Medicine is It?

Биодроксил is a prescription-only anti-infective agent that utilizes the active ingredient Cefadroxil to treat specific types of infections. It belongs to the first-generation cephalosporin antibiotic class, which places it within the larger beta-lactam family of compounds. This pharmacological type is clinically recognized for its stability when taken orally, distinguishing it from related antibiotics that require injection.

The drug is intended for oral administration and operates through a bactericidal mechanism, meaning it actively kills susceptible bacteria. Its classification as a first-generation cephalosporin ensures a strong focus on common Gram-positive bacteria, a profile that is well-established in pharmacological studies.

Composition, Origin, and Physical Form

The core of the preparation is the single active ingredient Cefadroxil, which is a semisynthetic compound, chemically derived from a natural base. Cefadroxil is frequently administered as its stable monohydrate salt, represented by the formula C16H17N3O5S cdot H2O.

Биодроксил is made available in several oral dosage forms, including capsules, tablets, and a powder for oral suspension that must be reconstituted into a liquid form. The availability of the oral suspension is a distinguishing factor, making the medication suitable for a wider age range, including children.

General Purpose of This Antibiotic

The general purpose of Биодроксил is the efficient elimination of the microorganisms responsible for bacterial infections, such as those that commonly affect the skin. Its primary action involves disrupting the structural integrity of the bacterial outer layer, specifically by preventing the necessary synthesis of the cell wall. This bactericidal method supports the body's ability to resolve an active infectious process caused by susceptible pathogens, fulfilling the role of a specialized tool in antimicrobial therapy.

Regulatory References

  1. NIH, Cefadroxil Classification
Advertisements

What side effects are possible with Биодроксил?

Official Safety Profile and Adverse Reactions

The safety profile of Биодроксил (Cefadroxil) is classified according to standard regulatory methods, grouping adverse reactions by frequency and affected body system. The most frequently reported issues are classified as Common effects, while rarer, more critical events are specifically highlighted in official labeling.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on their incidence, typically aligned with the EMA/ICH frequency bands:

Classification Examples of Officially Listed Adverse Reactions
Common (affecting ge 1/100 to <1/10) Gastrointestinal disturbances (e.g., Nausea, Diarrhea, Vomiting), Skin rash, Pruritus (itching).
Uncommon (ge 1/1,000 to <1/100) Fungal superinfection (e.g., Vaginal Mycoses).
Rare (affecting ge 1/10,000 to <1/1,000) Angioedema, Serum sickness-like reactions, Minor elevation of liver enzymes.

Serious Adverse Reactions and Safety Constraints

Regulatory documents mandate specific attention to severe, though rare, safety issues:

  • Anaphylactic Shock: A severe, acute, systemic allergic reaction that is listed as a possibility.
  • Pseudomembranous Colitis: A potentially serious inflammatory bowel condition associated with antibacterial use, which may arise during treatment or weeks after cessation.
  • Cross-Hypersensitivity: Official labeling cautions regarding the use of Cefadroxil in individuals with a known allergy to penicillin due to the risk of a cross-allergic reaction.
  • Population-Specific Caution: Specific safety considerations are documented for patients with impaired renal function due to the drug's primary pathway of excretion.

Time-Related and Laboratory Notes

The onset of serious gastrointestinal events can occur during treatment or after the final dose. Furthermore, the presence of Cefadroxil may result in a false positive reaction for glucose in the urine when specific copper-reduction testing methods are used, a regulatory note for laboratory safety.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the officially documented descriptions of overdose for Cefadroxil, based strictly on government regulatory labeling.

Overdose Manifestations and Risks

Acute oral overdosage is most commonly associated with gastrointestinal irritation. Documented manifestations include nausea, vomiting, and abdominal distress.

However, high drug concentrations may lead to Central Nervous System (CNS) toxicity, with severe outcomes potentially including convulsions or seizures. The official regulatory classification notes that overdose is typically considered non-life-threatening unless complicated by coexisting conditions.

Mandatory Emergency Actions

In the event of a known or suspected overdose, patients must seek immediate medical attention or contact emergency services immediately. Hospital monitoring is required to observe for signs of CNS toxicity and monitor vital signs and renal function.

Management and Considerations

No specific antidote is known for Cefadroxil overdose. Treatment involves symptomatic and supportive measures. Regulatory documents specify that procedures such as gastric lavage or the administration of activated charcoal may be used. For cases involving severe overdose or significantly impaired renal function, hemodialysis may be required to facilitate drug removal, as patients with kidney impairment face an increased risk of severe CNS effects.

Advertisements

Therapeutic Uses of Биодроксил

What Биодроксил Treats: Main Uses and Benefits

The primary role of Биодроксил is supportive management in clinical contexts involving susceptible bacterial pathogens in areas including the skin, throat, tonsils, and urinary tract. The medication is generally applied in clinical settings that involve acute or unstable symptom patterns.

It is commonly used across therapeutic domains where short-term symptomatic assistance is needed, relevant in conditions such as bacterial pharyngitis, tonsillitis, cellulitis, impetigo, and uncomplicated cystitis. It may also be applied as a prophylactic measure in high-risk patients or for managing pediatric middle ear infections. The treatment is applied in addressing symptoms related to physical discomfort and noticeable physiological strain, such as sore throat, swelling, and painful urination, and may help ease overall distress.

“The treatment is relevant in contexts involving inflammatory or irritative processes, offering symptomatic support that may help patients cope more steadily with difficult episodes.”


Quick Fact: Support for Localized Discomfort

The medication is commonly used to help manage symptoms associated with acute episodes, particularly the localized discomfort, redness, and swelling associated with skin and throat infections.

Regulatory References

  1. NIH MedlinePlus Drug Information on Cefadroxil
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Биодроксил (Cefadroxil) — Official Regulatory Information

Official regulatory documents define the eligibility for Cefadroxil based on allergy history, organ function, and age.

Category Official Regulatory Statements
Populations for whom use is contraindicated: Patients with a known allergy to the cephalosporin group of antibiotics or a history of severe allergic reaction to penicillins or other beta-lactam drugs.
Age-related eligibility rules: Approved for use in adults and pediatric patients. Older adults require caution, as they are more likely to have reduced renal function, necessitating monitoring. The capsule form is generally not recommended for young children due to formulation suitability.
Condition-specific eligibility rules: Patients with markedly impaired renal function (Creatinine Clearance <50 mL/min/1.73 m^2) require conditional use, with official labeling stating that caution and adjustment are necessary. Caution is also specified for individuals with a history of gastrointestinal disease, particularly colitis.
Pregnancy and lactation eligibility status: Pregnancy: Classified as FDA Pregnancy Category B, meaning use is generally permitted if clearly needed after assessment. Lactation: The medicine is excreted in low concentrations in human breast milk; use is allowed but requires caution.

These domains establish the official constraints and exclusions for Cefadroxil. The most absolute restriction is the Contraindication for patients with a documented hypersensitivity to the drug class. Use is permitted for broad populations, but is made conditional upon proper renal function status.

Advertisements

What should I know about interactions with other medicines?

The interaction profile for Биодроксил (Cefadroxil) is formally documented based on two main mechanisms: interference with renal clearance and alteration of intestinal bacterial flora. The following table details the most relevant regulatory statements on co-administration with other medicines.

Interacting Agents or Conditions Official Interaction Description
Probenecid (Renal Transport Inhibitor) Increases the plasma concentration of Cefadroxil by inhibiting its renal tubular secretion, thereby reducing drug clearance.
Aminoglycoside Antibiotics Increases the risk of nephrotoxicity and/or ototoxicity due to an additive pharmacodynamic effect.
Oral Anticoagulants (e.g., Warfarin) Increases the risk of bleeding through an effect on the coagulation cascade.
Oral Contraceptives (Estrogen-containing) Decreases the level or effect of the hormonal agent due to Cefadroxil's alteration of intestinal bacterial flora.
Digoxin (Oral) Increases the serum level or effect of Digoxin, also due to alteration of the intestinal flora.

Interaction-Related Restrictions and Considerations

Биодроксил may reduce the therapeutic effect of Live Bacterial Vaccines (such as Typhoid Vaccine Live), and co-administration is subject to regulatory restrictions. The drug's availability is not significantly affected by the presence of food. A critical interaction-related caution applies to individuals with markedly impaired renal function (creatinine clearance less than 50 mL/min/1.73 m^2). In this population, the drug's elimination is significantly slowed, resulting in increased drug exposure in the body.

Advertisements

Mechanism of Action

Molecular Targeting and Irreversible Cell Wall Inhibition

Cefadroxil acts as an irreversible inhibitor of bacterial enzymes called Penicillin-Binding Proteins (PBPs), which are responsible for the final cross-linking of the peptidoglycan layer in the bacterial cell wall. The drug achieves this by having its beta-lactam core bind covalently to the PBP active site, permanently disabling the enzyme and preventing the final cross-linking of the peptidoglycan layer.

Bactericidal Cascade and Osmotic Lysis

Inhibition of cell wall synthesis initiates a sequence of cellular events. By forming a critically weak cell wall, the bacterium can no longer withstand its own high internal osmotic pressure, leading to rapid rupture and structural disintegration (lysis). This mechanism relies on the bacterium being in its active growth phase, a requirement which causes the physiological result of targeted, lethal elimination of the susceptible microbial population, rather than merely inhibiting its growth.

️ Constraints and Enzymatic Mechanism Limitation

The drug’s mechanism is constrained by the ability of some bacteria to produce beta-Lactamase enzymes, which hydrolyze and inactivate the Cefadroxil molecule before it reaches its PBP target. Furthermore, bacteria with modified PBPs may exhibit reduced binding affinity, offering another mechanistic limitation where the drug cannot effectively engage its target, resulting in continued cell wall function.

Advertisements

Dosage and Administration Information

How to Use Биодроксил

Биодроксил (Cefadroxil) is administered exclusively via the oral route, available in capsules, tablets, and a powder for oral suspension. The official instructions for use establish precise patterns for dosing, frequency, and course duration, which must be followed as outlined.


Administration and Scheduling

Element Official Use Guidance
Dosing Regimens Adult doses typically range from 1 gram to 2 grams per day. The 1-gram daily dose is common for skin infections and pharyngitis, while 2 grams daily are used for more complicated urinary tract infections.
Frequency Pattern The total daily dose may be taken once daily or divided into two equal doses taken every 12 hours.
Intake Condition The medication may be taken without regard to meals. Ingestion with food is permitted and may assist in minimizing the occurrence of gastrointestinal disturbances.
Course Duration The minimum length of treatment for infections caused by Streptococcus pyogenes is 10 days. General treatment should continue for 2 to 3 days after symptoms have resolved.

Population and Preparation Rules

Dose Adjustment: Patients with impaired renal function require a modification of the dosing interval based on their creatinine clearance, commencing with a 1-gram loading dose followed by maintenance doses at extended intervals (e.g., 12, 24, or 36 hours). Pediatric dosing is based on body weight, typically 30 mg/kg per day.

Suspension Handling: The powder for oral suspension must be reconstituted with water as specified upon dispensing and must be shaken well before measuring each individual dose. If a dose is missed, it should be taken as soon as possible unless it is close to the time of the next scheduled dose; doses must not be doubled.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Биодроксил (Cefadroxil)

This overview summarizes the available research concerning the drug, detailing the types of clinical studies conducted, the outcomes that researchers explored, and what remains unclear or less studied. This information is based on official regulatory and scientific sources and is not intended as medical advice or a prediction of individual outcomes.


Evidence for Use in Skin and Soft Tissue Infections

Clinical research for Cefadroxil has included Randomized Controlled Trials (RCTs) and comparative studies to examine Cefadroxil in the context of skin and soft tissue infections, such as cellulitis and impetigo. Researchers primarily studied how the drug was observed in patients facing conditions associated with acute or disruptive episodes.

The main outcomes measured included the rates of clinical findings—which involved monitoring physical discomfort—and patterns related to the presence of susceptible bacteria. These findings describe patterns observed in the studies during the short-term treatment period, which typically lasted 5 to 10 days.

The existing evidence is generally based on the study of mild to moderate infections. The relevance of these older findings to current patterns of antimicrobial resistance is an ongoing area of surveillance.


Evidence for Use in Urinary Tract and Throat Infections

Studies have focused on conditions such as uncomplicated lower urinary tract infections (UTIs) and infections of the throat and tonsils (pharyngitis/tonsillitis).

For UTIs, research monitored the bacteriological status and symptom evolution over typical treatment courses of 7 to 14 days. These data show patterns related to the drug achieving and maintaining concentration levels that researchers studied for organism elimination.

For pharyngitis, trials consistently explored a 10-day regimen. Official regulatory documentation explicitly notes that clinical trials have not established whether Cefadroxil was evaluated for preventing subsequent non-suppurative complications, such as rheumatic fever.


What is Still Uncertain About the Research for Cefadroxil

The majority of the research is composed of studies exploring short-term symptom changes, meaning there is limited information for long-term outcomes or the durability of the response several months after treatment. This indicates that long-term effects are not fully established.

For more serious conditions, such as infections of the bone or joints, the available data are still emerging. These studies are often small, exploratory, and focused on measuring the drug levels in the body rather than on large-scale patient-reported outcomes. Comparative evidence is lacking for these serious infection scenarios.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Биодроксил (FAQ)

Q: Is it necessary to take Биодроксил exactly at the same time every day?

The regulatory schedule is structured to support the maintenance of the intended drug level in the body throughout the treatment course. Regulatory documents indicate that the total daily dose is prescribed to be taken in consistent intervals, either once daily or divided into two equal doses every 12 hours.

Q: What happens if someone accidentally misses taking Биодроксил for one day?

Official guidance addresses missing a single dose, stating it should be taken as soon as possible unless the next scheduled dose is near. Regulatory documents state that doubling a dose is not permitted to compensate for a missed administration. Missing a full day of therapy constitutes a deviation from the prescribed regimen.

Q: Does using alcohol occasionally interfere with the effects of Биодроксил?

Official labeling does not typically list alcohol as a formal interacting agent for Cefadroxil. However, a general cautionary approach is often taken during antibiotic therapy.

Q: Is the list of side effects in the official information complete, or are there others people experience?

The official documentation presents the drug's formal safety profile, which categorizes adverse reactions based on incidence rates observed in clinical trials and post-marketing reports. These reactions are classified by frequency, such as Common, Uncommon, and Rare, and is considered the formally documented safety profile.

Q: Are there specific symptoms that mean I should stop taking Биодроксил immediately?

Official labeling describes severe allergic reactions (e.g., Anaphylactic Shock) and potentially serious inflammatory bowel conditions (Pseudomembranous Colitis). These are events that require the administration of the drug to be discontinued immediately.

Q: Can taking Биодроксил cause weight changes?

Weight change is not specifically listed as a common or frequent side effect in the primary classification tables. However, very rare or unusual reports of weight loss have been noted as an adverse event in some regulatory sources, often in relation to severe gastrointestinal issues.

Q: Can individuals with chronic conditions like diabetes use Биодроксил?

The official eligibility map addresses caution for patients with impaired renal function or a history of colitis. The presence of any chronic condition affecting kidney function is noted as a condition requiring caution and medical monitoring.

Q: Why is the drug not recommended for children?

The drug is approved for use in both adults and pediatric patients, meaning it is not strictly contraindicated for all children. Official guidance specifically notes that the capsule form is generally not recommended for young children due to its physical formulation and suitability for that age group.

Q: Why is Биодроксил prescribed if the official texts say it's for 'general support'?

The general purpose of this medicine, as defined in regulatory documents, is the efficient elimination of susceptible bacterial pathogens. It is classified as an anti-infective agent and is not intended or prescribed for general health support or non-specific conditions.

Q: Can Биодроксил be used long-term, or is it only for short periods?

The established and officially researched uses of the drug are for treating specific, short-term bacterial infections, with typical durations ranging from 7 to 14 days. Regulatory research documents explicitly note that there is limited information for long-term outcomes or effects after prolonged use.

Q: What is the difference between Биодроксил and similar sounding non-prescription supplements?

Биодроксил is officially classified as a prescription-only anti-infective agent and a first-generation cephalosporin antibiotic. This means it has a defined, bactericidal mechanism for actively killing specific bacteria, distinguishing it from non-prescription supplements.

Q: Are there any common foods or drinks that might affect how Биодроксил works?

Official product information states that the medication may be taken without regard to meals and that its availability in the body is not significantly affected by the presence of food. Taking the drug with food is permitted and may help minimize gastrointestinal disturbances.

Q: Does Биодроксил affect mood or energy levels?

Official safety documents list some central nervous system effects as possible adverse reactions. These include dizziness, weakness, drowsiness, and nervousness, which may sometimes be perceived by the user as changes in their mood or energy levels.

Q: Is Биодроксил generally considered safe for older adults?

Use of the drug is permitted for older adults. However, official guidance requires caution because older adults are more likely to have reduced renal function (kidney function). The official guidance states that monitoring and potential dosage adjustments are required based on that function.

Q: What specific research or trials support the use of Биодроксил?

Clinical research for the active ingredient, Cefadroxil, has included Randomized Controlled Trials (RCTs) and comparative studies. These studies primarily examine the drug's effect in short-term treatments for conditions like skin and soft tissue infections, as well as urinary tract and throat infections.

Q: If I am taking another prescription medication, is it guaranteed to cause a problem with Биодроксил?

Official regulatory descriptions of drug interactions use terms such as Increases the risk or Increases the plasma concentration of another medicine. This indicates that co-administration creates a risk that requires medical assessment and is not a guaranteed problem.

Q: What are the most common reported interactions with over-the-counter pain relievers?

The official documentation provides specific warnings for co-administering the drug with agents that can affect kidney function, such as certain antibiotics. This caution extends to some agents found in over-the-counter pain relievers that may increase the risk of certain adverse effects, such as nephrotoxicity (risk to the kidneys).

Q: Does Биодроксил have any effect on sleep quality?

The official safety data lists sleeplessness (insomnia) as a very rare central nervous system adverse reaction that has been reported. Changes in sleep quality are noted as a possible adverse event that should be reported.

Q: Are there any known long-term effects reported from taking Биодроксил for many years?

The research evidence base has largely explored short-term changes and outcomes for acute infections. Regulatory studies note that there is limited information for long-term outcomes or the durability of the response several months after treatment.

Q: Is it okay to take vitamin C or multivitamins while using Биодроксил?

Regulatory summaries generally show no direct pharmacokinetic interaction between the drug and Vitamin C. However, the co-administration of any supplement is an element that regulatory bodies caution requires assessment.

Q: Is there a generic version of Биодроксил available?

Yes, the active ingredient, Cefadroxil, is available in multiple generic versions approved by regulatory bodies like the FDA. These include generic tablets and oral suspension forms that are determined to be therapeutically equivalent to the brand-name product.

Q: What happens when a person stops taking Биодроксил after a long time?

Regulatory documents highlight the importance of completing the full treatment course to prevent the development of drug-resistant bacteria. Serious gastrointestinal events, such as Pseudomembranous Colitis, can potentially occur even after the final dose of the medicine.

Q: Can Биодроксил be taken during flu or cold season for prevention?

No, the official purpose of this antibiotic is the elimination of susceptible bacterial pathogens. Official information notes that the medicine will not be effective against viral infections, such as the common cold or the flu.

Q: Why is it noted that the drug is contraindicated for people with certain kidney issues?

The absolute contraindication for the drug is an allergy to cephalosporin or penicillin-type antibiotics. Markedly impaired renal function (severe kidney issues) is listed as a condition requiring conditional use, meaning caution, adjustment of the dose, and monitoring are necessary.

Q: What do researchers mean when they describe Биодроксил as a 'modulator'?

Official texts and regulatory documents describe the drug's mechanism using more specific terms like irreversible inhibitor and bactericidal agent. The primary action is to disrupt the structure of the bacterial cell wall, which is more specific than the general term 'modulator.'

Q: Does the time of day matter when taking Биодроксил?

The medication may be taken without regard to meals, and the key factor is maintaining the prescribed 12-hour or 24-hour interval to ensure consistent drug levels. The time of day is secondary to adherence to the required dosing schedule.

Q: Is there a possibility of an allergic reaction to the inactive ingredients in Биодроксил?

Official regulatory warnings caution that the drug should be used with care in any patient who has a history of an allergy, particularly to drugs. This general caution extends to the possibility of a reaction to any of the ingredients, including inactive components.

Q: How long does the effect of a single dose of Биодроксил typically last in the body?

Pharmacokinetic data indicates that the half-life of Cefadroxil in the body is approximately 1.5 hours in individuals with normal kidney function. This half-life structure is consistent with the drug’s required dosing schedule of 12-hour or 24-hour intervals.

Q: Are there any specific lifestyle changes that must be avoided while using Биодроксил?

Official documentation notes that the drug can be taken without regard to food and does not list extensive lifestyle restrictions. However, the potential for interaction highlights the element that requires assessment according to regulatory standards.

Q: What kind of monitoring is typically recommended for patients taking Биодроксил?

Official guidance mandates that patients with impaired renal function require specific monitoring. This includes checking measures like creatinine clearance, which is necessary for following the regulatory requirements for dose modification and drug elimination.

Q: Is it confirmed that Биодроксил is not toxic to the liver?

The official safety profile lists Minor elevation of liver enzymes as a Rare adverse reaction that has been documented during post-marketing reports. This indicates that a potential for transient liver effects has been observed in some individuals.

Q: Are there specific warnings about driving or operating machinery while taking Биодроксил?

Safety labeling lists central nervous system effects such as dizziness, drowsiness, and vertigo as possible adverse reactions. Warnings about operating machinery are standard for drugs that have these documented side effects.

Q: Can the appearance or color of the tablet/capsule change over time?

Regulatory guidelines mandate that all forms of the drug, including tablets and capsules, must be stored in a manner that protects them from excess heat and moisture. These environmental conditions can potentially lead to physical degradation or changes in the medication's appearance.

Advertisements

How should Биодроксил be stored and disposed of?

Storage and Handling

Official regulatory guidelines for Биодроксил (Cefadroxil) specify distinct storage requirements for its different forms.

Dosage Form Required Storage Condition
Capsules, Tablets, Dry Powder Controlled Room Temperature (15 to 30 C); protect from excess heat and moisture.
Reconstituted Suspension Refrigerate immediately; keep container tightly closed.

All forms must be kept in a tightly closed container and stored out of the sight and reach of children. The medicine should not be stored in areas subject to excess heat or moisture. Any unused portion of the reconstituted oral suspension must be discarded after 14 days.

Disposal

To dispose of unused or outdated medicine, patients must consult a healthcare professional or pharmacist for instructions on proper disposal protocol.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Биодроксил found in:

A-Z Index: